Cargando…
Genetic spectrum and clinical characteristics of 3β-hydroxy-Δ(5)-C(27)-steroid oxidoreductase (HSD3B7) deficiency in China
BACKGROUND: Biallelic variants in HSD3B7 cause 3β-hydroxy-Δ(5)-C(27)-steroid oxidoreductase (HSD3B7) deficiency, a life-threatening but treatable liver disease. The goal of this study was to obtain detailed information on the correlation between the genotype and phenotype of HSD3B7 deficiency and to...
Autores principales: | Zhao, Jing, Setchell, Kenneth D. R., Gong, Ying, Sun, Yinghua, Zhang, Ping, Heubi, James E., Fang, Lingjuan, Lu, Yi, Xie, Xinbao, Gong, Jingyu, Wang, Jian-She |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501698/ https://www.ncbi.nlm.nih.gov/pubmed/34627351 http://dx.doi.org/10.1186/s13023-021-02041-7 |
Ejemplares similares
-
Novel Mutations in the 3β-hydroxy-Δ5-C27-steroid Dehydrogenase Gene (HSD3B7) in a Patient with Neonatal Cholestasis
por: Huang, He-Yu, et al.
Publicado: (2016) -
Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes
por: Zhang, Mei-Hong, et al.
Publicado: (2019) -
Prognosis and clinical characteristics of patients with 3β-hydroxy-Δ5-C27-steroid dehydrogenase deficiency diagnosed in childhood: A systematic review of the literature
por: Zhang, Yuan, et al.
Publicado: (2022) -
Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2018) -
BMX controls 3βHSD1 and sex steroid biosynthesis in cancer
por: Li, Xiuxiu, et al.
Publicado: (2023)